The Rheumatoid Arthritis market was valued at approximately USD 27 Billion in 2023 and is expected to grow at a strong CAGR of around 5% during the forecast period (2024-2032)
https://univdatos.com/repo...
https://univdatos.com/repo...
Rheumatoid Arthritis Market Size, Share & Trends 2032
The Rheumatoid Arthritis Market was valued at approximately USD 27 Billion in 2023 and is expected to grow at a strong CAGR of around 5% during 2024-2032. UCB S.A., F. HOFFMANN-LA ROCHE LTD, Pfizer Inc, ABBVIE INC. and Novartis AG are the major companies operating in this market.
https://univdatos.com/report/rheumatoid-arthritis-market/
01:57 PM - Sep 20, 2024 (UTC)
